Suppression of the neoplastic phenotype by transfection of phospholipase C β 3 to neuroendocrine tumor cells
- 7 May 1999
- journal article
- Published by Wiley in FEBS Letters
- Vol. 450 (3) , 210-216
- https://doi.org/10.1016/s0014-5793(99)00457-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethalityFEBS Letters, 1998
- Inhibition of Human Breast Epithelial HBL100 Cell Proliferation by a Dextran Derivative (CMDB7) with the FGF2 Autocrine LoopBiochemical and Biophysical Research Communications, 1997
- Hyperparathyroidism of multiple endocrine neoplasia type 1: Candidate gene and parathyroid calcium sensing protein expressionSurgery, 1995
- Candidate genes for multiple endocrine neoplasia type 1Journal of Internal Medicine, 1995
- Compartmentalization of Autocrine Signal Transduction Pathways in Sis-transformed NIH 3T3 CellsPublished by Elsevier ,1995
- Demonstration of Functionally Different Interactions between Phospholipase C-γ and the Two Types of Platelet-derived Growth Factor ReceptorsPublished by Elsevier ,1995
- The phospholipase C β3 gene located in the MEN1 region shows loss of expression in endocrine tumoursHuman Molecular Genetics, 1994
- Characterization of a Human Pancreatic Carcinoid in VitroPancreas, 1994
- Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragmentsJournal of Endocrinology, 1993
- Characterisation of a cell line (LCC-18) from a cultured human neuroendocrine-differentiated colonic carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991